Additional file 3: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

Publication date

December 2018

DOI

10.6084/m9.figshare.7446719.v1

Abstract

Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in women with ER-positive first breast cancer in the WECARE Study population. (DOCX 16 kb

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 3: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

Open link

Publication date

December 2018

DOI

10.6084/m9.figshare.7446719.v1

Abstract

Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in women with ER-positive first breast cancer in the WECARE Study population. (DOCX 16 kb

Extracted data

Lynn Chollet-Hinton (3467606)
Carey Anders (81107)
Chiu-Kit Tse (73020)
Mary Bell (3467609)
Yang Yang (45629)
Lisa Carey (408852)
Andrew Olshan (3403652)
Melissa Troester (3403661)

August 2016

Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...

Additional file 3: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Trygve Lofterød (5396501)
Elin Mortensen (5396498)
Hawa Nalwoga (845585)
Tom Wilsgaard (321883)
Hanne Frydenberg (3542120)
Terje Risberg (25586)
Anne Eggen (4100746)
Anne McTiernan (3542132)
Sura Aziz (655431)
Erik Wist (3542126)
Andreas Stensvold (3528713)
Jon Reitan (5396495)
Lars Akslen (4406518)
Inger Thune (315574)

June 2018

Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...

Additional file 4: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

December 2018

Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in women...

Additional file 5: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

December 2018

Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in Cauca...

Additional file 1: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

December 2018

CYP2D6 polymorphisms tested, primer sequences, and PCR conditions for genotyping. (XLSX 10 kb

Additional file 1: of Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study

Rikke Langballe (3571376)
Lene MellemkjĂŚr (3571391)
Kathleen Malone (3571382)
Charles Lynch (3571373)
Esther John (413149)
Julia Knight (34590)
Leslie Bernstein (3467)
Jennifer Brooks (3571379)
Michael Andersson (3439148)
Anne Reiner (3114798)
Xiaolin Liang (230778)
Meghan Woods (308567)
Patrick Concannon (3481)
Jonine Bernstein (3571388)

July 2016

Table S1. Characteristics of patients diagnosed with ER/PR-positive first breast cancer enrolled in ...

Additional file 3: of Association of tamoxifen resistance and lipid reprogramming in breast cancer

Susanne Hultsch (127184)
Matti Kankainen (19209)
Lassi Paavolainen (550942)
Ruusu-Maaria Kovanen (5684708)
Elina Ikonen (279424)
Sara Kangaspeska (127181)
Vilja Pietiäinen (5684714)
Olli Kallioniemi (69616)

August 2018

Statistical analysis of triglycerides, free cholesterol and cholesterol esters, LMP assay, and Lipid...

Additional file 3: of Alcohol-related breast cancer in postmenopausal women â effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial

Tine Kopp (3430238)
Ditte Jensen (3430247)
Gitte Ravn-Haren (436923)
Arieh Cohen (105631)
Helle Sommer (3430241)
Lars Dragsted (3430244)
Anne Tjonneland (23607)
David Hougaard (3430235)
Ulla Vogel (21241)

April 2016

Risk estimates for different combinations of CYP19A1 haplotypes in relation to risk of BC. (DOCX 12 ...

Additional file 2: Table S2. of Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study

Carrie Hruska (3584681)
Christopher Scott (512912)
Amy Conners (3584669)
Dana Whaley (3584675)
Deborah Rhodes (3584666)
Rickey Carter (3584684)
Michael OâConnor (3584687)
Katie Hunt (3584678)
Kathleen Brandt (3556067)
Celine Vachon (89914)

April 2016

Association of background parenchymal uptake (BPU) with breast cancer for ipsilateral vs. contralate...

Additional file 2: of Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer

Maria Apaya (5820440)
Jeng-Yuan Shiau (2327821)
Guo-Shiou Liao (839303)
Yu-Jen Liang (29024)
Chia-Wei Chen (395946)
Hsin-Chou Yang (19577)
Chi-Hong Chu (80551)
Jyh-Cherng Yu (146771)
Lie-Fen Shyur (471003)

May 2019

Supporting information for delineation of CYP epoxygenase-associated networks as theranostic targets...

Additional file 1: Table S1. of Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study

Humberto Parada (4676905)
Xuezheng Sun (3403646)
Jodie Fleming (4676902)
ClarLynda Williams-DeVane (4676899)
Erin Kirk (3566942)
Linnea Olsson (4676896)
Charles Perou (3530138)
Andrew Olshan (3403652)
Melissa Troester (3403661)

December 2017

Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. ...

Additional file 1: of Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer

J. Kuhlmann (3576038)
A. Bankfalvi (3576035)
K. Schmid (2449798)
R. Callies (3576032)
R. Kimmig (3576041)
P. Wimberger (3576029)
W. Siffert (3576047)
H. Bachmann (3576044)

August 2016

Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...

Additional file 1: of Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies

Renée Fortner (3495014)
Julia Sisti (4259701)
Boyang Chai (6456662)
Laura Collins (235142)
Bernard Rosner (274275)
Susan Hankinson (266693)
Rulla Tamimi (89929)
A. Eliassen (3398609)

March 2019

Table S1. Multivariate-adjusteda hazard ratios (HRs) and 95% confidence intervals for breast cancer ...

Additional file 1: Table S1. of Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study

Lynn Chollet-Hinton (3467606)
Carey Anders (81107)
Chiu-Kit Tse (73020)
Mary Bell (3467609)
Yang Yang (45629)
Lisa Carey (408852)
Andrew Olshan (3403652)
Melissa Troester (3403661)

August 2016

Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...

Additional file 3: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Trygve Lofterød (5396501)
Elin Mortensen (5396498)
Hawa Nalwoga (845585)
Tom Wilsgaard (321883)
Hanne Frydenberg (3542120)
Terje Risberg (25586)
Anne Eggen (4100746)
Anne McTiernan (3542132)
Sura Aziz (655431)
Erik Wist (3542126)
Andreas Stensvold (3528713)
Jon Reitan (5396495)
Lars Akslen (4406518)
Inger Thune (315574)

June 2018

Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...

Additional file 4: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

December 2018

Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in women...

Additional file 5: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

December 2018

Association between tamoxifen treatment and risk of CBC stratified by CYP2D6 activity score in Cauca...

Additional file 1: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Jennifer Brooks (3571379)
Elizabeth Comen (6067436)
Anne Reiner (3114798)
Irene Orlow (205195)
Siok Leong (6067439)
Xiaolin Liang (230778)
Lene MellemkjĂŚr (3571391)
Julia Knight (34590)
Charles Lynch (3571373)
Esther John (413149)
Leslie Bernstein (3467)
Meghan Woods (308567)
David Doody (6067442)
Kathleen Malone (3571382)
Jonine Bernstein (3571388)

December 2018

CYP2D6 polymorphisms tested, primer sequences, and PCR conditions for genotyping. (XLSX 10 kb

Additional file 1: of Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study

Rikke Langballe (3571376)
Lene MellemkjĂŚr (3571391)
Kathleen Malone (3571382)
Charles Lynch (3571373)
Esther John (413149)
Julia Knight (34590)
Leslie Bernstein (3467)
Jennifer Brooks (3571379)
Michael Andersson (3439148)
Anne Reiner (3114798)
Xiaolin Liang (230778)
Meghan Woods (308567)
Patrick Concannon (3481)
Jonine Bernstein (3571388)

July 2016

Table S1. Characteristics of patients diagnosed with ER/PR-positive first breast cancer enrolled in ...

Additional file 3: of Association of tamoxifen resistance and lipid reprogramming in breast cancer

Susanne Hultsch (127184)
Matti Kankainen (19209)
Lassi Paavolainen (550942)
Ruusu-Maaria Kovanen (5684708)
Elina Ikonen (279424)
Sara Kangaspeska (127181)
Vilja Pietiäinen (5684714)
Olli Kallioniemi (69616)

August 2018

Statistical analysis of triglycerides, free cholesterol and cholesterol esters, LMP assay, and Lipid...

Tine Kopp (3430238)
Ditte Jensen (3430247)
Gitte Ravn-Haren (436923)
Arieh Cohen (105631)
Helle Sommer (3430241)
Lars Dragsted (3430244)
Anne Tjonneland (23607)
David Hougaard (3430235)
Ulla Vogel (21241)

April 2016

Risk estimates for different combinations of CYP19A1 haplotypes in relation to risk of BC. (DOCX 12 ...

Additional file 2: Table S2. of Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study

Carrie Hruska (3584681)
Christopher Scott (512912)
Amy Conners (3584669)
Dana Whaley (3584675)
Deborah Rhodes (3584666)
Rickey Carter (3584684)
Michael OâConnor (3584687)
Katie Hunt (3584678)
Kathleen Brandt (3556067)
Celine Vachon (89914)

April 2016

Association of background parenchymal uptake (BPU) with breast cancer for ipsilateral vs. contralate...

Additional file 2: of Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer

Maria Apaya (5820440)
Jeng-Yuan Shiau (2327821)
Guo-Shiou Liao (839303)
Yu-Jen Liang (29024)
Chia-Wei Chen (395946)
Hsin-Chou Yang (19577)
Chi-Hong Chu (80551)
Jyh-Cherng Yu (146771)
Lie-Fen Shyur (471003)

May 2019

Supporting information for delineation of CYP epoxygenase-associated networks as theranostic targets...

Additional file 1: Table S1. of Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study

Humberto Parada (4676905)
Xuezheng Sun (3403646)
Jodie Fleming (4676902)
ClarLynda Williams-DeVane (4676899)
Erin Kirk (3566942)
Linnea Olsson (4676896)
Charles Perou (3530138)
Andrew Olshan (3403652)
Melissa Troester (3403661)

December 2017

Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. ...

Additional file 1: of Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer

J. Kuhlmann (3576038)
A. Bankfalvi (3576035)
K. Schmid (2449798)
R. Callies (3576032)
R. Kimmig (3576041)
P. Wimberger (3576029)
W. Siffert (3576047)
H. Bachmann (3576044)

August 2016

Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...

Additional file 1: of Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies

Renée Fortner (3495014)
Julia Sisti (4259701)
Boyang Chai (6456662)
Laura Collins (235142)
Bernard Rosner (274275)
Susan Hankinson (266693)
Rulla Tamimi (89929)
A. Eliassen (3398609)

March 2019

Table S1. Multivariate-adjusteda hazard ratios (HRs) and 95% confidence intervals for breast cancer ...

Additional file 1: Table S1. of Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study

Lynn Chollet-Hinton (3467606)
Carey Anders (81107)
Chiu-Kit Tse (73020)
Mary Bell (3467609)
Yang Yang (45629)
Lisa Carey (408852)
Andrew Olshan (3403652)
Melissa Troester (3403661)

August 2016

Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...

Additional file 3: of Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes

Trygve Lofterød (5396501)
Elin Mortensen (5396498)
Hawa Nalwoga (845585)
Tom Wilsgaard (321883)
Hanne Frydenberg (3542120)
Terje Risberg (25586)
Anne Eggen (4100746)
Anne McTiernan (3542132)
Sura Aziz (655431)
Erik Wist (3542126)
Andreas Stensvold (3528713)
Jon Reitan (5396495)
Lars Akslen (4406518)
Inger Thune (315574)

June 2018

Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...

Additional file 3: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Abstract

Extracted data

Additional file 3: of CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Abstract

Extracted data

Related items

Related items